[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Meier J.J., Granhall C., Hoevelmann U., Navarria A., Plum-Moerschel L., Ramesh C., Tannapfel A., Kapitza C
The FDA also explains that the drugs could cause weight loss, and that "weight loss offers no benefit to a pregnant patient and may cause fetal harm." Velazquez noted that in addition to there not being enough human research to show these drugs are safe during pregnancy, animal studies have shown complications
Ready to take the first step
While the share of ESI enrollees with a GLP-1 drug claim has been increasing, still only a relatively modest number of people have a claim Since 2012, the share of non-elderly adults with ESI that have a GLP-1 drug claim has grown more than eightfold (717.7% increase)
If chest pain persists beyond 48 hours, worsens despite conservative care, or develops new concerning features, schedule an urgent evaluation with your primary care physician or seek emergency department assessment